Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 775

1.

Entering an era of radiogenomics in prostate cancer risk stratification.

Soodana-Prakash N, Stoyanova R, Bhat A, Velasquez MC, Kineish OE, Pollack A, Parekh DJ, Punnen S.

Transl Androl Urol. 2018 Sep;7(Suppl 4):S443-S452. doi: 10.21037/tau.2018.07.04. Review.

2.

Assessment of specific versus combined purpose knowledge based models in prostate radiotherapy.

Bossart E, Duffy M, Simpson G, Abramowitz M, Pollack A, Dogan N.

J Appl Clin Med Phys. 2018 Oct 19. doi: 10.1002/acm2.12483. [Epub ahead of print]

PMID:
30338911
3.

Validation of electronic medical data: Identifying diabetes prevalence in general practice.

Henderson J, Barnett S, Ghosh A, Pollack AJ, Hodgkins A, Win KT, Miller GC, Bonney A.

Health Inf Manag. 2018 Oct 3:1833358318798123. doi: 10.1177/1833358318798123. [Epub ahead of print]

PMID:
30278786
4.

Postpartum psychological distress after emergency team response during childbirth.

Silverstein RG, Centore M, Pollack A, Barrieau G, Gopalan P, Lim G.

J Psychosom Obstet Gynaecol. 2018 Sep 11:1-7. doi: 10.1080/0167482X.2018.1512095. [Epub ahead of print]

PMID:
30204531
5.

Oral Biofilms: Development, Control, and Analysis.

Berger D, Rakhamimova A, Pollack A, Loewy Z.

High Throughput. 2018 Aug 31;7(3). pii: E24. doi: 10.3390/ht7030024. Review.

6.

Towards a universal MRI atlas of the prostate and prostate zones : Comparison of MRI vendor and image acquisition parameters.

Padgett KR, Swallen A, Pirozzi S, Piper J, Chinea FM, Abramowitz MC, Nelson A, Pollack A, Stoyanova R.

Strahlenther Onkol. 2018 Aug 23. doi: 10.1007/s00066-018-1348-5. [Epub ahead of print]

PMID:
30140944
7.

Exposure to bisphenol A, chlorophenols, benzophenones, and parabens in relation to reproductive hormones in healthy women: A chemical mixture approach.

Pollack AZ, Mumford SL, Krall JR, Carmichael AE, Sjaarda LA, Perkins NJ, Kannan K, Schisterman EF.

Environ Int. 2018 Nov;120:137-144. doi: 10.1016/j.envint.2018.07.028. Epub 2018 Aug 10.

PMID:
30092451
8.

Optimizing patient's selection for prostate biopsy: A single institution experience with multi-parametric MRI and the 4Kscore test for the detection of aggressive prostate cancer.

Punnen S, Nahar B, Soodana-Prakash N, Koru-Sengul T, Stoyanova R, Pollack A, Kava B, Gonzalgo ML, Ritch CR, Parekh DJ.

PLoS One. 2018 Aug 9;13(8):e0201384. doi: 10.1371/journal.pone.0201384. eCollection 2018.

9.

Magnetic resonance imaging (MRI)-based radiomics for prostate cancer radiotherapy.

Yang F, Ford JC, Dogan N, Padgett KR, Breto AL, Abramowitz MC, Dal Pra A, Pollack A, Stoyanova R.

Transl Androl Urol. 2018 Jun;7(3):445-458. doi: 10.21037/tau.2018.06.05. Review.

10.

Contemporary role of postoperative radiotherapy for prostate cancer.

Dal Pra A, Abramowitz MC, Stoyanova R, Pollack A.

Transl Androl Urol. 2018 Jun;7(3):399-413. doi: 10.21037/tau.2018.06.01. Review.

11.

Disparities in Hispanic/Latino and non-Hispanic Black men with low-risk prostate cancer and eligible for active surveillance: a population-based study.

Katz JE, Chinea FM, Patel VN, Balise RR, Venkatramani V, Gonzalgo ML, Ritch C, Pollack A, Parekh DJ, Punnen S.

Prostate Cancer Prostatic Dis. 2018 Jul 9. doi: 10.1038/s41391-018-0057-6. [Epub ahead of print]

PMID:
29988097
12.

Acute Epithelial Toxicity Is Prognostic for Improved Prostate Cancer Response to Radiation Therapy: A Retrospective, Multicenter, Cohort Study.

Eade T, Choudhury A, Pollack A, Abramowitz M, Chinea FM, Guo L, Kennedy J, Louw S, Hruby G, Kneebone A, West C.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):957-963. doi: 10.1016/j.ijrobp.2018.04.009. Epub 2018 Apr 11.

PMID:
29976508
13.

Plasmonic Optical Imaging of Gold Nanorods Localization in Small Animals.

Xu K, Shi J, Pourmand A, Udayakumar TS, Dogan N, Zhao W, Pollack A, Yang Y.

Sci Rep. 2018 Jun 19;8(1):9342. doi: 10.1038/s41598-018-27624-6.

14.

Diabetic macular edema treated with ranibizumab following bevacizumab failure in Israel (DERBI study).

Ehrlich R, Pokroy R, Segal O, Goldstein M, Pollack A, Hanhart J, Barak Y, Kehat R, Shulman S, Vidne O, Abu Ahmad W, Chowers I.

Eur J Ophthalmol. 2018 Jun 1:1120672118782102. doi: 10.1177/1120672118782102. [Epub ahead of print]

PMID:
29916263
15.

An Automated Multiparametric MRI Quantitative Imaging Prostate Habitat Risk Scoring System for Defining External Beam Radiation Therapy Boost Volumes.

Stoyanova R, Chinea F, Kwon D, Reis IM, Tschudi Y, Parra NA, Breto AL, Padgett KR, Pra AD, Abramowitz MC, Kryvenko ON, Punnen S, Pollack A.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):821-829. doi: 10.1016/j.ijrobp.2018.06.003. Epub 2018 Jun 13.

PMID:
29908220
16.

Supporting Collaborative Health Tracking in the Hospital: Patients' Perspectives.

Mishra SR, Miller AD, Haldar S, Khelifi M, Eschler J, Elera RG, Pollack AH, Pratt W.

Proc SIGCHI Conf Hum Factor Comput Syst. 2018;2018. pii: 650. doi: 10.1145/3173574.3174224. Epub 2018 Apr 21.

17.

The Influence of Ethnic Heterogeneity on Prostate Cancer Mortality After Radical Prostatectomy in Hispanic or Latino Men: A Population-based Analysis.

Velasquez MC, Chinea FM, Kwon D, Prakash NS, Barboza MP, Gonzalgo ML, Ritch CR, Pollack A, Parekh DJ, Punnen S.

Urology. 2018 Jul;117:108-114. doi: 10.1016/j.urology.2018.03.036. Epub 2018 Apr 6.

PMID:
29630954
18.

Culturally Sensitive Assessment of Anxious-Depressive Distress in Vietnam: Avoiding Category Truncation.

Hinton DE, Pollack AA, Weiss B, Trung LT.

Transcult Psychiatry. 2018 Jun;55(3):384-404. doi: 10.1177/1363461518764500. Epub 2018 Apr 6.

PMID:
29623775
19.

Using dynamic treatment regimes to understand erythropoietin-stimulating agent hyporesponsiveness.

Pollack AH, Oron AP, Flynn JT, Munshi R.

Pediatr Nephrol. 2018 Aug;33(8):1411-1417. doi: 10.1007/s00467-018-3948-9. Epub 2018 Apr 4.

PMID:
29619552
20.

Bioluminescence Tomography Guided Small-Animal Radiation Therapy and Tumor Response Assessment.

Shi J, Udayakumar TS, Xu K, Dogan N, Pollack A, Yang Y.

Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):848-857. doi: 10.1016/j.ijrobp.2018.01.068. Epub 2018 Feb 2.

PMID:
29534897
21.

Validation of a deformable MRI to CT registration algorithm employing same day planning MRI for surrogate analysis.

Padgett KR, Stoyanova R, Pirozzi S, Johnson P, Piper J, Dogan N, Pollack A.

J Appl Clin Med Phys. 2018 Mar;19(2):258-264. doi: 10.1002/acm2.12296. Epub 2018 Feb 23.

22.

Correction: Management of vertebral compression fracture in general practice: BEACH program.

Megale RZ, Pollack A, Britt H, Latimer J, Naganathan V, McLachlan AJ, Ferreira ML.

PLoS One. 2018 Feb 22;13(2):e0193531. doi: 10.1371/journal.pone.0193531. eCollection 2018.

23.

Parity associated with telomere length among US reproductive age women.

Pollack AZ, Rivers K, Ahrens KA.

Hum Reprod. 2018 Apr 1;33(4):736-744. doi: 10.1093/humrep/dey024.

PMID:
29452389
24.

Dietary lipophilic iron alters amyloidogenesis and microglial morphology in Alzheimer's disease knock-in APP mice.

Peters DG, Pollack AN, Cheng KC, Sun D, Saido T, Haaf MP, Yang QX, Connor JR, Meadowcroft MD.

Metallomics. 2018 Mar 1;10(3):426-443. doi: 10.1039/c8mt00004b. Epub 2018 Feb 9.

PMID:
29424844
25.

Comparison Between Adjuvant and Early-Salvage Postprostatectomy Radiotherapy for Prostate Cancer With Adverse Pathological Features.

Hwang WL, Tendulkar RD, Niemierko A, Agrawal S, Stephans KL, Spratt DE, Hearn JW, Koontz BF, Lee WR, Michalski JM, Pisansky TM, Liauw SL, Abramowitz MC, Pollack A, Moghanaki D, Anscher MS, Den RB, Zietman AL, Stephenson AJ, Efstathiou JA.

JAMA Oncol. 2018 May 10;4(5):e175230. doi: 10.1001/jamaoncol.2017.5230. Epub 2018 May 10.

PMID:
29372236
26.

You Can't Treat a Problem if You Don't Recognize It.

Pollack AH, Flynn JT.

Pediatrics. 2018 Feb;141(2). pii: e20173756. doi: 10.1542/peds.2017-3756. No abstract available.

PMID:
29371240
27.

C-Reactive protein in relation to fecundability and anovulation among eumenorrheic women.

Radin RG, Sjaarda LA, Silver RM, Nobles CJ, Mumford SL, Perkins NJ, Wilcox BD, Pollack AZ, Schliep KC, Plowden TC, Schisterman EF.

Fertil Steril. 2018 Feb;109(2):232-239.e1. doi: 10.1016/j.fertnstert.2017.10.025. Epub 2018 Jan 6.

PMID:
29317123
28.

Reply.

Singh RP, Lehmann R, Martel J, Jong K, Pollack A, Tsorbatzoglou A, Staurenghi G, Cervantes-Coste Cervantes G, Alpern L, Modi S, Svoboda L, Adewale A, Jaffe GJ.

Ophthalmology. 2018 Jan;125(1):e9-e10. doi: 10.1016/j.ophtha.2017.08.026. No abstract available.

PMID:
29268878
29.

Reply.

Singh RP, Lehmann R, Martel J, Jong K, Pollack A, Tsorbatzoglou A, Staurenghi G, Cervantes-Coste Cervantes G, Alpern L, Modi S, Svoboda L, Adewale A, Jaffe GJ.

Ophthalmology. 2018 Jan;125(1):e4-e6. doi: 10.1016/j.ophtha.2017.07.024. No abstract available.

PMID:
29268874
30.

Reply.

Singh RP, Lehmann R, Martel J, Jong K, Pollack A, Tsorbatzoglou A, Staurenghi G, Cervantes-Coste Cervantes G, Alpern L, Modi S, Svoboda L, Adewale A, Jaffe GJ.

Ophthalmology. 2018 Jan;125(1):e11-e12. doi: 10.1016/j.ophtha.2017.08.023. No abstract available.

PMID:
29268872
31.

Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.

Spratt DE, Zhang J, Santiago-Jiménez M, Dess RT, Davis JW, Den RB, Dicker AP, Kane CJ, Pollack A, Stoyanova R, Abdollah F, Ross AE, Cole A, Uchio E, Randall JM, Nguyen H, Zhao SG, Mehra R, Glass AG, Lam LLC, Chelliserry J, du Plessis M, Choeurng V, Aranes M, Kolisnik T, Margrave J, Alter J, Jordan J, Buerki C, Yousefi K, Haddad Z, Davicioni E, Trabulsi EJ, Loeb S, Tewari A, Carroll PR, Weinmann S, Schaeffer EM, Klein EA, Karnes RJ, Feng FY, Nguyen PL.

J Clin Oncol. 2018 Feb 20;36(6):581-590. doi: 10.1200/JCO.2017.74.2940. Epub 2017 Nov 29.

PMID:
29185869
32.

Automatic Detection and Quantitative DCE-MRI Scoring of Prostate Cancer Aggressiveness.

Parra NA, Pollack A, Chinea FM, Abramowitz MC, Marples B, Munera F, Castillo R, Kryvenko ON, Punnen S, Stoyanova R.

Front Oncol. 2017 Nov 10;7:259. doi: 10.3389/fonc.2017.00259. eCollection 2017.

33.

Multi-institutional Evaluation of Elective Nodal Irradiation and/or Androgen Deprivation Therapy with Postprostatectomy Salvage Radiotherapy for Prostate Cancer.

Ramey SJ, Agrawal S, Abramowitz MC, Moghanaki D, Pisansky TM, Efstathiou JA, Michalski JM, Spratt DE, Hearn JWD, Koontz BF, Liauw SL, Pollack A, Anscher MS, Den RB, Stephans KL, Zietman AL, Lee WR, Stephenson AJ, Tendulkar RD.

Eur Urol. 2018 Jul;74(1):99-106. doi: 10.1016/j.eururo.2017.10.009. Epub 2017 Nov 9.

PMID:
29128208
34.

OM-101 Decreases the Fibrotic Response Associated with Proliferative Vitreoretinopathy.

Dvashi Z, Ben-Yaakov K, Weinberg T, Greenwald Y, Pollack A.

J Ophthalmol. 2017;2017:1606854. doi: 10.1155/2017/1606854. Epub 2017 Oct 4.

35.

Opportunities and Design Considerations for Peer Support in a Hospital Setting.

Haldar S, Mishra SR, Khelifi M, Pollack AH, Pratt W.

Proc SIGCHI Conf Hum Factor Comput Syst. 2017 May;2017:867-879. doi: 10.1145/3025453.3026040.

36.

Ethnic heterogeneity and prostate cancer mortality in Hispanic/Latino men: a population-based study.

Chinea FM, Patel VN, Kwon D, Lamichhane N, Lopez C, Punnen S, Kobetz EN, Abramowitz MC, Pollack A.

Oncotarget. 2017 Jul 6;8(41):69709-69721. doi: 10.18632/oncotarget.19068. eCollection 2017 Sep 19.

37.

Barriers to global health development: An international quantitative survey.

Weiss B, Pollack AA.

PLoS One. 2017 Oct 3;12(10):e0184846. doi: 10.1371/journal.pone.0184846. eCollection 2017.

38.

Problems managed and medications prescribed during encounters with people with autism spectrum disorder in Australian general practice.

Birch RC, Foley KR, Pollack A, Britt H, Lennox N, Trollor JN.

Autism. 2018 Nov;22(8):995-1004. doi: 10.1177/1362361317714588. Epub 2017 Sep 15.

PMID:
28914073
39.

Delineation of Tumor Habitats based on Dynamic Contrast Enhanced MRI.

Chang YC, Ackerstaff E, Tschudi Y, Jimenez B, Foltz W, Fisher C, Lilge L, Cho H, Carlin S, Gillies RJ, Balagurunathan Y, Yechieli RL, Subhawong T, Turkbey B, Pollack A, Stoyanova R.

Sci Rep. 2017 Aug 29;7(1):9746. doi: 10.1038/s41598-017-09932-5.

40.

Blood lead, cadmium and mercury in relation to homocysteine and C-reactive protein in women of reproductive age: a panel study.

Pollack AZ, Mumford SL, Sjaarda L, Perkins NJ, Malik F, Wactawski-Wende J, Schisterman EF.

Environ Health. 2017 Aug 8;16(1):84. doi: 10.1186/s12940-017-0293-6.

41.

No abatement of steroid injections for tennis elbow in Australian General Practice: A 15-year observational study with random general practitioner sampling.

Vicenzino B, Britt H, Pollack AJ, Hall M, Bennell KL, Hunter DJ.

PLoS One. 2017 Jul 20;12(7):e0181631. doi: 10.1371/journal.pone.0181631. eCollection 2017.

42.

Molecular Profiling in the Practice of Radiation Oncology.

Marples B, Pollack A.

Oncology (Williston Park). 2017 Jul 15;31(7):571-2. No abstract available.

43.

Antibiotics for acute respiratory infections in general practice: comparison of prescribing rates with guideline recommendations.

McCullough AR, Pollack AJ, Plejdrup Hansen M, Glasziou PP, Looke DF, Britt HC, Del Mar CB.

Med J Aust. 2017 Jul 17;207(2):65-69.

PMID:
28701117
44.

Chronic and Acute Ozone Exposure in the Week Prior to Delivery Is Associated with the Risk of Stillbirth.

Mendola P, Ha S, Pollack AZ, Zhu Y, Seeni I, Kim SS, Sherman S, Liu D.

Int J Environ Res Public Health. 2017 Jul 6;14(7). pii: E731. doi: 10.3390/ijerph14070731.

45.

General practice encounters for young patients with autism spectrum disorder in Australia.

Foley KR, Pollack AJ, Britt HC, Lennox NG, Trollor JN.

Autism. 2018 Oct;22(7):784-793. doi: 10.1177/1362361317702560. Epub 2017 Jul 7.

PMID:
28683578
46.

Optical molecular imaging-guided radiation therapy part 1: Integrated x-ray and bioluminescence tomography.

Shi J, Udayakumar TS, Wang Z, Dogan N, Pollack A, Yang Y.

Med Phys. 2017 Sep;44(9):4786-4794. doi: 10.1002/mp.12415. Epub 2017 Jul 20.

PMID:
28627007
47.

Optical molecular imaging-guided radiation therapy part 2: Integrated x-ray and fluorescence molecular tomography.

Shi J, Udayakumar TS, Wang Z, Dogan N, Pollack A, Yang Y.

Med Phys. 2017 Sep;44(9):4795-4803. doi: 10.1002/mp.12414. Epub 2017 Jul 21.

PMID:
28626876
48.

Efficacy of nepafenac ophthalmic suspension 0.1% in improving clinical outcomes following cataract surgery in patients with diabetes: an analysis of two randomized studies.

Singh RP, Staurenghi G, Pollack A, Adewale A, Walker TM, Sager D, Lehmann R.

Clin Ophthalmol. 2017 May 29;11:1021-1029. doi: 10.2147/OPTH.S132030. eCollection 2017.

49.

[TREATMENT OPTIONS FOR DIABETIC MACULAR EDEMA].

Berco E, Rappoport D, Pollack A.

Harefuah. 2017 Feb;156(2):109-113. Review. Hebrew.

PMID:
28551902
50.

[PHACOEMULSIFICATION IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (AMD)].

Rappoport D, Goldberg M, Bukelman A, Katz H, Goldberg L, Pollack A.

Harefuah. 2017 Feb;156(2):79-83. Hebrew.

PMID:
28551897

Supplemental Content

Loading ...
Support Center